<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In order to determine the incidence and causes of <z:hpo ids='HP_0011420'>death</z:hpo> during the first 100 days after BMT (early <z:hpo ids='HP_0011420'>deaths</z:hpo>) in a pediatric population we have examined data reported in the AIEOP BMT Registry </plain></SENT>
<SENT sid="1" pm="."><plain>Up to July 1990, data on 486 children who underwent allogeneic (180) or autologous (306) BMT were evaluable </plain></SENT>
<SENT sid="2" pm="."><plain>The children had <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (148 cases), <z:hpo ids='HP_0011009'>acute</z:hpo> non-lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (127 cases), <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> (82 cases), <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (15 cases), <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (nine cases), <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>, <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> or <z:e sem="disease" ids="C0267971" disease_type="Disease or Syndrome" abbrv="">storage diseases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The overall survival is 55% for allogeneic HLA matched and 38% for autologous transplants at 5 years, 24% for HLA mismatched graft at 2 years </plain></SENT>
<SENT sid="4" pm="."><plain>Out of the 486 children, 70 (14%) died during the first 100 days after BMT: 33/306 (11%) after autologous BMT, 24/150 (16%) after allogeneic matched BMT and 13/30 (43%) after mismatched BMT </plain></SENT>
<SENT sid="5" pm="."><plain>Causes of early <z:hpo ids='HP_0011420'>death</z:hpo> were as follows: disease progression: 12 children (10/306 after autologous and 2/180 after allogeneic BMT); <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>: 12 children (five after autologous and seven after allogeneic BMT); <z:hpo ids='HP_0006515'>interstitial pneumonitis</z:hpo>: 21 children (seven after autologous and 14 after allogeneic BMT); <z:hpo ids='HP_0001635'>cardiac failure</z:hpo>: five children (four after autologous BMT); <z:e sem="disease" ids="C0948441" disease_type="Disease or Syndrome" abbrv="VOD">veno-occlusive disease</z:e>: eight children (three after autologous, five after allogeneic BMT); <z:hpo ids='HP_0001919'>acute renal failure</z:hpo>: three children (one after autologous and two after allogeneic BMT); multiple organ failure: two cases (one after autologous BMT); <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo>: three children (one after autologous BMT); <z:hpo ids='HP_0000822'>hypertension</z:hpo>: one child; <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD: three children (12% of early <z:hpo ids='HP_0011420'>deaths</z:hpo> after allogeneic BMT) </plain></SENT>
</text></document>